Pro PSA : a “pro cancer” form of PSA?
- 31 December 2005
- journal article
- research article
- Published by Elsevier in Medical Hypotheses
- Vol. 64 (1), 92-95
- https://doi.org/10.1016/j.mehy.2004.06.006
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Serum Pro Prostate Specific Antigen Improves Cancer Detection Compared to Free and Complexed Prostate Specific Antigen in Men With Prostate Specific Antigen 2 to 4 Ng/MlJournal of Urology, 2003
- Evaluation of Proprostate Specific Antigen for Early Detection of Prostate Cancer in Men With a Total Prostate Specific Antigen Range of 4.0 to 10.0 Ng/MlJournal of Urology, 2003
- Proenzyme psa for the early detection of prostate cancer in the 2.5–4.0 ng/ml total psa range: preliminary analysisUrology, 2003
- Biology of Prostate-Specific AntigenJournal of Clinical Oncology, 2003
- Pro PSA: a more cancer specific form of prostate specific antigen for the early detection of prostate cancer.The Keio Journal of Medicine, 2003
- LONG-TERM BIOCHEMICAL DISEASE-FREE AND CANCER-SPECIFIC SURVIVAL FOLLOWING ANATOMIC RADICAL RETROPUBIC PROSTATECTOMYUrologic Clinics of North America, 2001
- “BPSA,” a specific molecular form of free prostate-specific antigen, is found predominantly in the transition zone of patients with nodular benign prostatic hyperplasiaUrology, 2000
- Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic DiseaseJAMA, 1998
- A precursor form of PSA (pPSA) is a component of the free PSA in prostate cancer serumUrology, 1997
- Prostate Cancer Detection in Men With Serum PSA Concentrations of 2.6 to 4.0 ng/mL and Benign Prostate ExaminationJAMA, 1997